Related Experiment Videos
An aspirin a day to prevent prematurity
1Department of Obstetrics/Gynecology, University of Tennessee, Memphis, Memphis.
Clinics in Perinatology
|June 1, 1992
Summary
Low-dose aspirin can help prevent preterm birth caused by fetal growth restriction and preeclampsia. This treatment is effective for high-risk pregnancies by balancing prostacyclin and thromboxane levels.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Intrauterine fetal growth retardation and preeclampsia are major causes of preterm birth globally.
- A key factor in these conditions is an imbalance between prostacyclin and thromboxane A2 production.
- This imbalance affects vascular function during pregnancy.
Purpose of the Study:
- To evaluate the efficacy and safety of low-dose aspirin in preventing preeclampsia and fetal growth retardation.
- To assess the impact of low-dose aspirin on prostacyclin and thromboxane A2 balance.
- To determine the role of low-dose aspirin in reducing preterm birth.
Main Methods:
- Review of randomized and uncontrolled trials.
- Analysis of existing literature on low-dose aspirin in pregnancy.
- Assessment of prostacyclin and thromboxane A2 levels in relation to aspirin use.
Main Results:
- Low-dose aspirin appears to correct the functional imbalance between prostacyclin and thromboxane A2.
- This leads to an improved prostacyclin to thromboxane ratio.
- Trials suggest efficacy in reducing preterm birth in selected high-risk pregnancies.
Conclusions:
- Low-dose aspirin is a potentially effective intervention for preventing preeclampsia and fetal growth retardation.
- The drug helps restore a healthier balance of key vascular compounds.
- It offers a strategy to reduce preterm birth in specific high-risk obstetric populations.